Evidence map›Paper›PMID 17541016›Full record

ArticleAmerican journal of respiratory and critical care medicine2007

Plasminogen is an important regulator in the pathogenesis of a murine model of asthma.

Carmen M Swaisgood, Mark A Aronica, Shadi Swaidani, Edward F Plow

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Observational
  2. siRNA-mediated reduction of a circulating protein in swine using lipid nanoparticles.Molecular therapy. Methods & clinical development · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. A critical role for plasminogen in inflammation.The Journal of experimental medicine · 2020
    Review
  7. Fibrinogen Is a Specific Trigger for Cytolytic Eosinophil Degranulation.Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  12. Dual role of the leukocyte integrin αMβ2 in angiogenesis.Journal of immunology (Baltimore, Md. : 1950) · 2014
    Article
  13. Article
  14. A new function for old drugs.Cell cycle (Georgetown, Tex.) · 2010
    Article
  15. Article
  16. Article
  17. Plasminogen is an important regulator in the pathogenesis of a murine model of asthma.American journal of respiratory and critical care medicine · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Carmen M SwaisgoodCleveland Clinic, Department of Molecular Cardiology, NB50, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Mark A Aronica
Shadi Swaidani
Edward F Plow
Cleveland Clinic Lerner College of Medicine · US

Funding

THE CLASSICAL AND ALTERNATIVE PATHWAYS OF FIBRINOLYSISR01HL017964 · NHLBI · SCRIPPS RESEARCH INSTITUTE · PI PLOW, EDWARD FRANKLIN · 1985 to 2015
$5.6M
Extracellular Matrix Synthesis and Turnover in AsthmaR01AI067816 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI ARONICA, MARK A · 2006 to 2010
$1.9M
NHLBI NIH HHS HL-17964NIAID NIH HHS R01 AI067816
6 · The paper itself

Abstract

rationaleAsthma is a syndrome whose common pathogenic expression is inflammation of the airways. Plasminogen plays an important role in cell migration and is also implicated in tissue remodeling, but its role in asthma has not been defined.

objectivesTo test whether plasminogen is a critical component in the development of asthma.

methodsWe used a mouse model of ovalbumin-induced pulmonary inflammation in Plg(+/+), Plg(+/-), and Plg(-/-) mice. MEASUREMENTS AND MAIN

resultsThe host responses measured included lung morphometry, and inflammatory mediators and cell counts were assessed in bronchoalveolar lavage fluid. Bronchoalveolar lavage demonstrated a marked increase in eosinophils and lymphocytes in ovalbumin-treated Plg(+/+) mice, which were reduced to phosphate-buffered saline-treated control levels in Plg(+/-) or Plg(-/-) mice. Lung histology revealed peribronchial and perivascular leukocytosis, mucus production, and increased collagen deposition in ovalbumin-treated Plg(+/+) but not in Plg(+/-) or Plg(-/-) mice. IL-5, tumor necrosis factor-alpha, and gelatinases, known mediators of asthma, were detected in bronchoalveolar lavage fluid of ovalbumin-treated Plg(+/+) mice, yet were reduced in Plg(-/-) mice. Administration of the plasminogen inhibitor, tranexamic acid, reduced eosinophil and lymphocyte numbers, mucus production, and collagen deposition in the lungs of ovalbumin-treated Plg(+/+) mice.

conclusionsThe decreased inflammation in the lungs of Plg(-/-) mice and its blockade with a plasminogen inhibitor indicate that plasminogen plays an important role in orchestrating the asthmatic response and suggests that plasminogen may be a therapeutic target for the treatment of asthma.

Indexed as

AnimalsAntifibrinolytic AgentsAsthmaBronchoalveolar Lavage FluidCollagenDisease Models, AnimalEosinophilsGelatinasesInflammationInterleukin-5LeukocytosisLungLymphocytesMiceMice, Inbred C57BLMucusAntifibrinolytic AgentsCollagenGelatinasesInterleukin-5PlasminogenTranexamic AcidTumor Necrosis Factor-alpha

Identifiers

PMID17541016
PMCPMC1994216
OpenAlexW2150369147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.